10 ml retatrutide Dosage Guide 2026: Phase 3 TRIUMPH Data Retatrutide 10mg Vial for Research

The starting dose of tirzepatide is 2.5 mg once a week, and after 4 weeks, the dose is increased to the therapeutic dose of 5 mg and administered subcutaneously in patients with T2D

The following classification of PDM according to four distinct morphologic patterns has been proposed: Spitzoid type, blue nevus-like, PDM with an associated intradermal nevus, and a not otherwise specified group

While the timeline is consistent across most patients, your metabolic health, medication type, and lifestyle habits determine how quickly changes appear

Wegovy is another injectable medication for obesity, while Rybelsus is an oral diabetes medication